Sabaa International Company for Pharmaceutical and Chemical Industry announced a private placement of 6,000,000 common shares at an issue price of EGP 2 per share for gross proceeds of EGP 12,000,000 on April 7, 2021. Pursuant to the transaction, the issued share capital will increase from EGP 88,000,000 to EGP 100,000,000. The transaction has been approved by the Egyptian Financial Regulatory Authority.